Y-mAbs Therapeutics, Inc.

NasdaqGS:YMAB Stock Report

Market Cap: US$537.1m

Y-mAbs Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:YMAB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Jun 24SellUS$841,050Thomas GadIndividual70,000US$12.03
10 Jun 24SellUS$8,664Gérard BerIndividual722US$12.00
23 May 24SellUS$395,563Thomas GadIndividual32,351US$13.00
05 Mar 24SellUS$27,837Susan SmithIndividual1,682US$16.55
05 Mar 24SellUS$64,116Thomas GadIndividual3,900US$16.44
05 Mar 24SellUS$28,283Vignesh RajahIndividual1,711US$16.53
15 Dec 23SellUS$1,001,000Thomas GadIndividual150,000US$6.83
11 Dec 23BuyUS$890,411Wg Biotech ApsCompany127,549US$7.01
11 Dec 23BuyUS$44,232Wg Biotech ApsCompany6,455US$6.85
29 Nov 23BuyUS$309,477Wg Biotech ApsCompany51,837US$5.97
28 Nov 23BuyUS$521,294Wg Biotech ApsCompany93,187US$5.81
21 Nov 23SellUS$795,383Thomas GadIndividual150,000US$5.31

Insider Trading Volume

Insider Buying: YMAB insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of YMAB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,255,4222.86%
Hedge Funds2,233,6105.09%
Private Companies4,562,61910.4%
VC/PE Firms8,253,90318.8%
General Public8,550,68919.5%
Institutions19,026,39543.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 72.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.4%
Wg Biotech Aps
4,559,233US$55.8m0%no data
7.52%
HBM Partners Ltd.
3,297,800US$40.4m0%4.22%
6.51%
BlackRock, Inc.
2,857,257US$35.0m-2.05%no data
6.29%
Acorn Bioventures
2,761,825US$33.8m0%43.11%
5.09%
Paradigm Biocapital Advisors LP
2,233,610US$27.3m0%1.09%
5%
Sofinnova Investment, Inc.
2,194,278US$26.9m0%1.7%
4.72%
The Vanguard Group, Inc.
2,069,517US$25.3m-7.79%no data
4.17%
Polar Capital Holdings Plc
1,831,000US$22.4m-11%0.08%
3.7%
Point72 Asset Management, L.P.
1,625,669US$19.9m3,560%0.04%
2.43%
D. E. Shaw & Co., L.P.
1,068,159US$13.1m-19.3%0.02%
1.71%
State Street Global Advisors, Inc.
751,073US$9.2m-1.37%no data
1.7%
Pictet Asset Management Limited
746,101US$9.1m0%0.01%
1.69%
Geode Capital Management, LLC
742,749US$9.1m0.57%no data
1.42%
Claus Moller-San Pedro
622,928US$7.6m0%no data
1.37%
Acadian Asset Management LLC
602,314US$7.4m-24.9%0.02%
1.34%
Caligan Partners, LP
587,276US$7.2m-44%2.08%
1.3%
Soleus Capital Management, L.P.
570,982US$7.0m263%0.65%
0.95%
Dimensional Fund Advisors LP
418,699US$5.1m33.7%no data
0.79%
Boothbay Fund Management, LLC
346,511US$4.2m-50.1%0.14%
0.76%
Goldman Sachs Asset Management, L.P.
335,696US$4.1m-12.6%no data
0.76%
Thomas Gad
332,281US$4.1m-23.6%no data
0.73%
Northern Trust Global Investments
321,715US$3.9m-1.14%no data
0.64%
Millennium Management LLC
282,551US$3.5m1,240%no data
0.61%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
266,859US$3.3m-33.1%no data
0.57%
Charles Schwab Investment Management, Inc.
250,225US$3.1m1.1%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.